期刊文献+

评价舒洛地特联合辛伐他汀治疗糖尿病下肢血管病变的疗效 被引量:8

Evaluation of Curative Effect of Sulodexide Combined With Ssimvastatin in the Treatment of Diabetic Lower Extremity Vascular Disease
下载PDF
导出
摘要 目的评价舒洛地特联合辛伐他汀治疗糖尿病下肢血管病变的疗效。方法选取我院50例糖尿病下肢血管病变患者,使用舒洛地特联合辛伐他汀进行治疗,三个月后观察其下肢血管病变状况以及各项指标的改善情况,并与治疗前进行对比,分析其临床疗效。结果治疗后患者的症状明显改善,且各项指标显著优化(P<0.05)。结论使用舒洛地特联合辛伐他汀治疗糖尿病下肢血管病变,具有显著疗效。 ObjectiveTo evaluate the curative effect of sulodexide combined with simvastatin in the treatment of diabetic lower extremity vascular disease.Methods Selected 50 cases of diabetic patients with lower extremity vascular disease in our hospital, used sulodexide combined with simvastatin treatment, observed the improvement in the lower extremity vascular disease status and each index after three months, analysed the clinical efficacy.ResultsThe patient's symptoms improved obviously after treatment, and the indicators of significant optimization (P〈0.05). Conclusion The use of sulodexide combined with simvastatin in the treatment of diabetic lower extremity vascular disease has obvious curative effect.
作者 田永红 李蕊
出处 《中国继续医学教育》 2015年第1期161-161,共1页 China Continuing Medical Education
关键词 糖尿病下肢血管病变 舒洛地特 辛伐他汀 Diabetes vascular disease in the lower limbs Sulodexide Simvastatin
  • 相关文献

参考文献2

二级参考文献18

  • 1许樟荣.糖尿病足病的病因及流行病学[J].中国实用内科杂志,2007,27(7):485-487. 被引量:72
  • 2林少达,林楚佳,王爱红,赵湜,严励,王鹏华,杜玉茗,王战建,肖正华,马学毅,陈国昌,周迎生,李强,卞茸文,毛季萍,许樟荣.中国部分省市糖尿病足调查及神经病变分析[J].中华医学杂志,2007,87(18):1241-1244. 被引量:30
  • 3Zucchi P,Ferrari P,Spina ML,et al.Diabetic foot:from diag-nosis to therapy.G Ital Nefrol,2005,22:S20-S22.
  • 4Leymarie F,Richard JL,Malgrange D.Factors associatedwith diabetic patients at high risk for foot ulceration.DiabetesMetab,2005,31:603-605.
  • 5Bechert S,Witte M,Wiche C,et al.A new wound-based se-verity score for diabetic foot ulcers:aprospective analysis of1000patients.Diabetes Care,2006,29:988-992.
  • 6Leese G,MacAlpine R,Schofield C,et a1.Scottish foot ulcerrisk score predicts foot ulcer healing in a regional specialist footclinic.Diabetes Care,2007,30:2064-2069.
  • 7Prompers L,Huijberts M,Apelqvist J,et al.High Prevalence ofisehaemia、infeetion、and serious comorbidity、in patients with dia-betic foot disease in Europe.Diabetologia,2007,50:18-25.
  • 8Boulton AJ.The diabetic foot a global view.Diabet MetabRes Rev,2000,16:S2-S5.
  • 9Kristová V,Lísková S,Sotníková R. Sulodexide improves endothelial dysfunction in streptozotocin-induced diabetes in rats[J].Physiological Research,2008,(03):491-494.
  • 10Murdoch AD,Liu B,Schwarting R. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain Ⅲ and by in situ hybridization[J].Journal of Histochemistry and Cytochemistry,1994,(02):239-249.

共引文献130

同被引文献40

  • 1吴伯军.2型糖尿病患者尿微量白蛋白与下肢血管病变的关系[J].中国药物经济学,2013,8(3):193-194.
  • 2Masola,V., Zaza, G., Gambaro, G,et al. Sulodexide and gly- cosaminoglycans in the progression of renal disease []]. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association- Euro- pean Renal Association,2014,29:i74-i79.
  • 3Hilary J. Bews,Jules C. Carlson,Aruni Jha, et al.Simuhaneous quantification of simvastatin and simvastatin hydroxy acid in blood serum at physiological pH by ultrahigh performance liquid chromatography-tandem mass spectrometry (UHPLC/ MS/MS)[J].Journal of chromatography, B,Analytical technolo- gies in the biomedical and life sciences,2014,947/948:145- 150.
  • 4Lewis EJ,Lewis JB,Greene T,et al.Sulodexide for kidney protecfion in type 2 diabetes patiens with micro-albuminuria:A randomized controlled trial[J].Am J Kidney Dis,2013,56(9):256-259.
  • 5Gladdi AV,Cicero AF,Gambaro G.Nephroprotective action of glycosaminoglycans:Why the pha-rmacological properties of sulodexide might be reconsidered[J].Int J Nephrol Renovasc Dis,2013,80(9):734-743.
  • 6Khanna R.Clinical presentation&management of glomenrular diseases:hematuria,nephritic&nephrotic syndrome[J].Missouri Med,2011,108(1):33-36.
  • 7Cirujeda JL,Granado PC.A study on the safety,efficacy,and efficiency of sulodexide compared with acenocoumarol in secondary prophylaxis in patients with deep venous thrombosis[J].Angiology,2006,57(1):53-64.
  • 8宋梅,李海英.可溶性P-选择素与糖尿病下肢血管病变的相关性[J].中国药物经济学,2013,3(4):293-295.
  • 9Masola V, Zaza G, Gambaro G, et al. Sulodexide and gly co- saminoglycans in the progression of renal disease[J].Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - Euro-pean Renal Associ- ation, 2014,29 : 74- 79.
  • 10Hilary J Bews, Jules C. Carlson, Aruni Jha, et al. Simultaneous quantification of simvastatin and simvastatin hydroxy acid in blood serum at physiological pH by ultrahigh performance liquid chro- matography - tandem mass spectrometry ( UHPLC/MS/MS ) [J]. Journal of chromatography, B ,Analytical technolo-gies in the bio- medical and life sciences,2014,947/948 : 145-150.

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部